King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a
live webcast of its presentation scheduled for Wednesday, September 3,
2008, at 9:10 a.m., Eastern Daylight Time, at the Thomas Weisel Partners
Healthcare Conference at the Four Seasons Hotel in Boston,
Massachusetts. The presentation may include a discussion of the Company’s
marketed products, pipeline, strategy for growth, strategic
opportunities, financial results and expectations, and other matters
relating to its business. Interested persons may access the live webcast
via the internet on the King Pharmaceuticals website at http://www.kingpharm.com/web_casts.asp.
A replay of the webcast may be accessed at this same link.
About King Pharmaceuticals, Inc.
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and
acquisitions, of novel branded prescription pharmaceutical products and
technologies that complement the Company’s
focus in specialty-driven markets, particularly neuroscience, hospital
and acute care. King strives to be a leader and partner of choice in
bringing innovative, clinically-differentiated medicines and
technologies to market.
About Forward-looking Statements
This release contains forward-looking statements which reflect management’s
current view of future events and operations, including, but not limited
to, statements pertaining to the anticipated webcast of the Company’s
presentation on September 3, 2008. These forward-looking statements
involve certain significant risks and uncertainties, and actual results
may differ materially from the forward-looking statements. An important
factor which may cause results to differ is whether King is able to
webcast the presentation on September 3, 2008 as currently planned. King
does not undertake to publicly update or revise any of its
forward-looking statements even if experience or future changes show
that the indicated results or events will not be realized.
King Pharmaceuticals, Inc.
James E. Green, 423-989-8125
Executive
Vice President, Corporate Affairs
or
David E. Robinson,
423-989-7045
Senior Director, Corporate Affairs
